title: Minocycline attenuates hypoxia-inducible factor-1α expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies.
abstract: Hypoxia-inducible factor (HIF)-1α is the key cellular survival protein under hypoxia, and is associated with tumor progression and angiogenesis. We have recently shown the inhibitory effects of minocycline on ovarian tumor growth correlated with attenuation of vascular endothelial growth factor (VEGF) and herein report a companion laboratory study to test if these effects were the result of HIF-1α inhibition. In vitro, human ovarian carcinoma cell lines (A2780, OVCAR-3 and SKOV-3) were utilized to examine the effect of minocycline on HIF-1 and its upstream pathway components to elucidate the underlying mechanism of action of minocycline. Mice harboring OVCAR-3 xenografts were treated with minocycline to assess the in vivo efficacy of minocycline in the context of HIF-1. Minocycline negatively regulated HIF-1α protein levels in a concentration-dependent manner and induced its degradation by a mechanism that is independent of prolyl-hydroxylation. The inhibition of HIF-1α was found to be associated with up-regulation of endogenous p53, a tumor suppressor with confirmed role in HIF-1α degradation. Further studies demonstrated that the effect of minocycline was not restricted to proteasomal degradation and that it also caused down-regulation of HIF-1α translation by suppressing the AKT/mTOR/p70S6K/4E-BP1 signaling pathway. Minocycline treatment of mice bearing established ovarian tumors, led to suppression of HIF-1α accompanied by up-regulation of p53 protein levels and inactivation of AKT/mTOR/p70S6K/4E-BP1 pathway. These data reveal the therapeutic potential of minocycline in ovarian cancer as an agent that targets the pro-oncogenic factor HIF-1α through multiple mechanisms.
authors.affiliation: Department of Surgery, St George Hospital Sydney, Australia.
authors.forename: Parvin
authors.initials: P
authors.lastname: Ataie-Kachoie
authors.affiliation: Department of Surgery, St George Hospital Sydney, Australia.
authors.forename: Mohammad H
authors.initials: MH
authors.lastname: Pourgholami
authors.affiliation: University of New South Wales Department of Surgery, St George and Sutherland Clinical School Sydney, Australia.
authors.forename: Farnaz
authors.initials: F
authors.lastname: Bahrami-B
authors.affiliation: University of New South Wales Department of Surgery, St George and Sutherland Clinical School Sydney, Australia.
authors.forename: Samina
authors.initials: S
authors.lastname: Badar
authors.affiliation: Department of Surgery, St George Hospital Sydney, Australia ; University of New South Wales Department of Surgery, St George and Sutherland Clinical School Sydney, Australia.
authors.forename: David L
authors.initials: DL
authors.lastname: Morris
keywords: AKT; HIF-1; Minocycline; VEGF; mTOR; ovarian cancer; p53